Bio-Rad Laboratories (BIO) Current Deferred Tax Assets (2009 - 2012)
Bio-Rad Laboratories' (BIO) quarterly Current Deferred Tax Assets came in at $57.8 million in Q4 2012, up 7.39% year-on-year from $53.8 million in Q1 2012, and up 7.39% on a QoQ basis from $53.8 million in Q4 2011.
Bio-Rad Laboratories (BIO) Current Deferred Tax Assets (2009 - 2012) Analysis & Trends
Bio-Rad Laboratories (BIO) has 4 years of Current Deferred Tax Assets data on file, last reported at $57.8 million in Q4 2012.
- On a quarterly basis, Current Deferred Tax Assets rose 7.39% year-over-year to $57.8 million in Q4 2012; TTM through Dec 2012 was $57.8 million, a 7.39% increase from a year earlier, with the FY2012 full-year figure at $57.8 million, up 7.39% from the prior year.
- Current Deferred Tax Assets for Q4 2012 stood at $57.8 million, up from $53.8 million in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for BIO reached as high as $57.8 million in Q4 2012 and fell as low as $43.1 million in Q4 2009.
- Historically, Current Deferred Tax Assets has averaged $50.7 million across 4 years, with a median of $50.9 million in 2010.
- Across the five-year window, Current Deferred Tax Assets climbed 11.99% in 2011 and rose 7.39% in 2012, its largest moves.
- Year by year, Current Deferred Tax Assets stood at $43.1 million in 2009, then climbed by 11.41% to $48.0 million in 2010, then increased by 11.99% to $53.8 million in 2011, then rose by 7.39% to $57.8 million in 2012.
- Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $57.8 million in Q4 2012, $53.8 million in Q4 2011, and $48.0 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 57.75 Mn |
| Dec 31, 2012 | 57.75 Mn |
| Dec 31, 2011 | 53.78 Mn |
| Dec 31, 2011 | 53.78 Mn |
| Dec 31, 2010 | 48.02 Mn |
| Dec 31, 2010 | 48.02 Mn |
| Dec 31, 2009 | 43.10 Mn |
| Dec 31, 2009 | 43.10 Mn |